UnitedHealth Directors Receive Deferred Stock Units Amid Latest Award Rounds

UnitedHealth Group (UNH) directors received multiple rounds of quarterly deferred stock unit (DSU) grants on April 1, 2026, disclosed via SEC Form 4 filings. The awards span a range of unit counts: Scott Gottlieb and Kristen Gil each received 320 DSUs, Charles D. Baker received 343 DSUs, Timothy Flynn received 350 DSUs, and Frederick McNabb III received 388 DSUs. Paul Garcia received 206 DSUs plus 137 shares of common stock. The grants are immediately vested but must be retained until the director leaves the board, structurally aligning board incentives with long-term shareholder returns.

The timing places these compensation disclosures against a challenging backdrop for UNH. The stock has fallen roughly 45% over the past year to approximately 59, driven by a DOJ investigation, a landmark CEO murder in December 2024, and CEO Andrew Witty's resignation in May 2025. Returning CEO Stephen Hemsley faces UNH's first projected revenue decline in a decade, with 2026 guidance calling for revenue above 39 billion — down 2% year-over-year — as the company exits unprofitable Medicare Advantage markets and sheds low-margin Medicaid contracts. A.88 billion Q4 2025 charge included 99 million in cyberattack remediation costs.

Despite headwinds, analyst sentiment remains constructive on UNH. Of 49 Wall Street analysts tracked, the consensus is Strong Buy with a median price target of 61 — implying roughly 39% upside from current levels. The board's DSU grant structure keeps directors financially aligned with the recovery thesis. Investors will get a clearer view of progress when UNH reports Q1 2026 results before the market opens on April 21, 2026, marking Hemsley's first earnings call since retaking the helm.